Diseases, Conditions, Syndromes

T-cells with a license to kill viruses

A research group led by Kyoto University has produced the world's first pluripotent stem cell-derived killer T-cell drug to treat COVID-19. The University has filed a patent application ahead of full-scale drug development.

Overweight & Obesity

New drug candidate reverses obesity in mice

Researchers at Karolinska Institutet may have found a new way to treat obesity and related disorders by targeting the cells' mitochondria. A study published in Nature Metabolism shows that a specific class of drugs that block ...

Medications

Researchers race to develop Paxlovid replacement

Researchers from Rutgers believe they are among the leaders in a race to find an oral COVID-19 treatment to supplement or replace Paxlovid—an antiviral medication that helps keep high-risk patients out of the hospital.

page 1 from 9